Inhibitory effects of INF-γ on HIV-1 replication in latently infected cells

Biochemical and Biophysical Research Communications

Volumn 291, Issue 4, 2002, Pages 890-896

  Sarol, Lilen C ^a   Imai, Kenichi ^a   Asamitsu, Kaori ^a   Tetsuka, Toshifumi ^a   Okamoto, Takashi ^a   Barzaga, Nina G ^b  

^a NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

^b UNIVERSITY OF THE PHILIPPINES MANILA   (Philippines)

Author keywords

Class II MHC; IFN ; JAK STAT pathway; Latent infection; Statins; Tat

Indexed keywords

ANTIVIRUS AGENT; CCNT1 PROTEIN, HUMAN; CYCLINE; DNA BINDING PROTEIN; GAMMA INTERFERON; HLA ANTIGEN CLASS 2; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; SIMVASTATIN; STAT1 PROTEIN; STAT1 PROTEIN, HUMAN; TRANSACTIVATOR PROTEIN; PROTEINASE INHIBITOR; RECOMBINANT GAMMA INTERFERON;

ARTICLE; BIOLOGICAL MODEL; BIOSYNTHESIS; CELL LINE; DOSE RESPONSE; DRUG EFFECT; GROWTH, DEVELOPMENT AND AGING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; REPORTER GENE; TRANSACTIVATION; VIRUS LATENCY; VIRUS REPLICATION; ANTIVIRAL ACTIVITY; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DYSLIPIDEMIA; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LATENT PERIOD; PRIORITY JOURNAL; VIRUS INHIBITION;

ANTIVIRAL AGENTS; CELL LINE; CYCLINS; DNA-BINDING PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE PRODUCTS, TAT; GENES, REPORTER; HISTOCOMPATIBILITY ANTIGENS CLASS II; HIV-1; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INTERFERON TYPE II; MODELS, BIOLOGICAL; PHOSPHORYLATION; SIMVASTATIN; STAT1 TRANSCRIPTION FACTOR; TRANS-ACTIVATION (GENETICS); TRANS-ACTIVATORS; VIRUS LATENCY; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0036018442     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.2002.6532     Document Type: Article

References (33)

1. Therapeutic targeting of human immunodeficiency virus type-1 latency: Current clinical realities and future scientific possibilities
2. Reservoirs for HIV-1: Mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy
3. Latent reservoirs of HIV: Obstacles to the eradication of virus
4. Type I cytokine production and low prevalence of viral isolation correlate with long-term nonprogression in HIV infection
5. Assessment of type 1 and type 2 cytokines in HIV type 1-infected individuals: Impact of highly active antiretroviral therapy
6. IL-13 and IFN-γ secretion by activated T cells in HIV-1 infection associated with viral suppression and a lack of disease progression
7. Reduction of IFN-gamma and IL-2 production by peripheral lymphocytes of HIV-exposed seronegative subjects
8. Regulation of MHC class II expression by interferon-γ mediated by the transactivator gene CIITA
9. The molecular basis of MHC II deficiency and transcriptional control of MHC II gene expression
10. CIITA is a transcriptional coactivator that is recruited to MHC class II promoters by multiple synergistic interactions with an enhanceosome complex
11. Regulation of MHC class II genes: Lessons from a disease
12. Tat competes with CIITA for the binding to P-TEFb and blocks the expression of MHC II genes in HIV infection
13. Repression of MHC determinants in HIV infection
14. Treatment of hyperlipidemia in HIV-1 infected patients
15. Epidemiological and clinical aspects of the metabolic complications of HIV infection: The fat redistribution syndrome
16. Adverse metabolic consequences of HIV protease inhibitor therapy: The search for a central mechanism
17. The HMG-CoA reductase inhibitor simvastatin inhibits IFN-γ induced MHC class II expression in human vascular endothelial cells
18. Inhibition of interferon-γ-mediated microvascular endothelial cell major histocompatibility complex class II gene activation by HMG-CoA reductase inhibitors
19. α-Lipoic acid blocks HIV-1 LTR-dependent expression of hygromycin resistance in THP-1 stable transformants
20. Anti-Tat MTT assay: A novel anti-HIV drug screening system using the viral regulatory network of replication
21. Anti-rheumatic compound aurothioglucose inhibits tumor necrosis factor-α-induced HIV-1 replication in latently infected OM 10.1 and Ach2 cells
22. Inhibition of HIV-1 replication by fasudil hydrochloride
23. NF-κB subunit p65 binds to 53BP2 and inhibits cell death induced by 53BP2
24. 2/M arrest after DNA damage
25. Reciprocal modulation of transcriptional activities between HIV-1 Tat and MHC II transactivator CIITA
26. The ability of positive transcription elongation factor B to transactivate human immunodeficiency virus transcription depends on a functional kinase domain, cyclin T1 and Tat
27. Inhibition of nuclear factor-κB-mediated transcription by association with the amino-terminal enhancer of split, a Groucho-related protein lacking WD40 repeats
28. Identification of a novel inhibitor of nuclear factor-κB, RelA-associated inhibitor
29. Interferons and bacterial lipopolysaccharide protect macrophages from productive infection by human immunodeficiency virus in vitro
30. Inhibition of human immunodeficiency virus infection in human colon epithelial cells by recombinant interferon-gamma
31. Antagonistic effect of interferon-γ on tat-induced transactivation of HIV long terminal repeat
32. P-TEFb kinase is required for HIV Tat transcriptional activation in vivo and in vitro
33. + T cell demographics and dynamics in lymphatic tissues